Pancreatic insulinoma: Current issues and trends

Hepatobiliary and Pancreatic Diseases International

Volumn 9, Issue 3, 2010, Pages 234-241

  Vaidakis, Dennis ^a   Karoubalis, John ^a   Pappa, Theodora ^a   Piaditis, George ^a   Zografos, George N ^a  

^a IASO GENERAL HOSPITAL   (Greece)

Author keywords

Diagnosis; Insulinoma; Neuroendocrine tumor; Pancreas; Treatment

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID DEXTRO PHENYL 1 TYROSINE 3 OCTREOTIDE; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID GA 67; 4 DIHYDROXY 6 FLUORO DEXTRO LEVO PHENYLANANINE; 5 HYDROXY LEVO TRYPTOPHAN C 5; DIAZOXIDE; FLUORODEOXYGLUCOSE F 18; GLUCOCORTICOID; INSULIN; PENTETREOTIDE IN 111; PHENYTOIN; SOMATOSTATIN RECEPTOR 2; STREPTOZOCIN; TRACER; UNCLASSIFIED DRUG; VERAPAMIL;

ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; ENDOSCOPIC ECHOGRAPHY; HUMAN; HYPERINSULINISM; HYPOGLYCEMIA; INSULINOMA; LABORATORY TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PANCREAS RESECTION; PANCREATIC INSULINOMA; PANCREATICODUODENECTOMY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; REVIEW; SENSITIVITY ANALYSIS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TUMOR LOCALIZATION; ULTRASOUND; ABDOMINAL SURGERY; DIAGNOSTIC IMAGING; FINE NEEDLE ASPIRATION BIOPSY; HISTORY; LAPAROSCOPY; PANCREATIC NEOPLASMS; PATIENT SELECTION; PREDICTIVE VALUE; TREATMENT OUTCOME; TRENDS;

BIOPSY, FINE-NEEDLE; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENDOSONOGRAPHY; HISTORY, 20TH CENTURY; HUMANS; INSULINOMA; LAPAROSCOPY; PANCREATECTOMY; PANCREATIC NEOPLASMS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 77953815932     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHOclassification. Ann N Y Acad Sci 2004;1014:13-27.
2. Boukhman MP, Karam JH, Shaver J, Siperstein AE, Duh QY, lark OH. Insulinoma-experience from 1950 to 1995. West J Med 1998;169:98-104.
3. Alexakis N, Neoptolemos JP. Pancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol 2008;22:183-205.
4. Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 2008; 29:22-32.
5. Grant CS. Insulinoma. Best Pract Res Clin Gastroenterol 2005;19:783-798.
6. Larsen PR, Kronenberg HM, Melmed S, Polonsky KS. Williams textbook of endocrinology (10th ed.). Philadelphia: WB Saunders;2003. ISBN: 0-7216-9184-6
7. Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 2006;103:2334-2339.
8. McClure RD, Brush BE. Experiences with islet cell tumors. Arch Surg 1949;59:507-513.
9. Shampo MA, Kyle RA. Frederick banting-Nobel laureate for discovery of insulin. Mayo Clin Proc 2005;80:576.
10. Clapesattle H. The Doctors Mayo, University of Minnesota Press;1975. ISBN: 0-8166-0465-7
11. Hunt PS. Adult hypoglycaemia associated with neoplasia. A report of three cases with a note on the use of diazoxide. Aust N Z J Surg 1966;35:295-299.
12. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954;16:363-371.
13. Gagner M, Pomp A, Herrera MF. Early experience with laparoscopic resections of islet cell tumors. Surgery 1996;120: 1051-1054.
14. Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer 2008;15:409-427.
15. Kimura W, Kuroda A, Morioka Y. Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 1991;36:933-942.
16. Grimelius L, Hultquist GT, Stenkvist B. Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material. Virchows Arch A Pathol Anat Histol 1975;365:275-288.
17. Service FJ, McMahon MM, O'Brien PC, Ballard DJ. Functioning insulinoma-incidence, recurrence, and longterm survival of patients: a 60-year study. Mayo Clin Proc 1991;66:711-719.
18. Mukai K, Grotting JC, Greider MH, Rosai J. Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method. Am J Surg Pathol 1982;6:387-399.
19. Jensen RT. Pancreatic neuroendocrine tumors: overview of recent advances and diagnosis. J Gastrointest Surg 2006;10: 324-326.
20. Nikfarjam M, Warshaw AL, Axelrod L, Deshpande V, Thayer SP, Ferrone CR, et al. Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg 2008;247:165-172.
21. Jonkers YM, Claessen SM, Perren A, Schmid S, Komminoth P, Verhofstad AA, et al. Chromosomal instability predicts metastatic disease in patients with insulinomas. Endocr Relat Cancer 2005;12:435-447.
22. Falconi M, Bettini R, Boninsegna L, Crippa S, Butturini G, Pederzoli P. Surgical strategy in the treatment of pancreatic neuroendocrine tumors. JOP 2006;7:150-156.
23. Moertel CG, Lefkopoulo M, Lipsitz S, Hahn RG, Klaassen D. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. N Engl J Med 1992;326:519-523.
24. Vig S, Lewis M, Foster KJ, Stacey-Clear A. Lessons to be learned: a case study approach insulinoma presenting as a change in personality. J R Soc Promot Health 2001;121:56-61.
25. Placzkowski KA, Vella A, Thompson GB, Grant CS, Reading CC, Charboneau JW, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab 2009;94:1069-1073.
26. Coelho C, Druce MR, Grossman AB. Diagnosis of insulinoma in a patient with hypoglycemia without obvious hyperinsulinemia. Nat Rev Endocrinol 2009;5:628-631.
27. McPhee SJ, Papadakis MA, Tierney LM. Current Medical Diagnosis & Treatment. 49th ed. McGraw Hll Publishers Inc; 2003. ISBN: 0071591249/ 9780071591249
28. Gerich JE, Mokan M, Veneman T, Korytkowski M, Mitrakou A. Hypoglycemia unawareness. Endocr Rev 1991;12:356-371.
29. Kisiel M, Marsons L. Recognizing and responding to hyperglycaemic emergencies. Br J Nurs 2009;18:1094-1098.
30. Grant CS. Gastrointestinal endocrine tumours. Insulinoma. Baillieres Clin Gastroenterol 1996;10:645-671.
31. Service FJ, Natt N. The prolonged fast. J Clin Endocrinol Metab 2000;85:3973-3974.
32. Hirshberg B, Livi A, Bartlett DL, Libutti SK, Alexander HR, Doppman JL, et al. Forty-eight-hour fast: the diagnostic test for insulinoma. J Clin Endocrinol Metab 2000;85:3222-3226.
33. Imamura M, Hattori Y, Nishida O, Honda T, Shimada Y, Miyahara T, et al. Unresponsiveness of insulinoma cells to secretin: significance of the secretin test in patients with insulinoma. Pancreas 1990;5:467-473.
34. Service FJ, O'Brien PC, Kao PC, Young WF Jr. C-peptide suppression test: effects of gender, age, and body mass index; implications for the diagnosis of insulinoma. J Clin Endocrinol Metab 1992;74:204-210.
35. Malouf R, Brust JC. Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol 1985;17:421-430.
36. Fischer KF, Lees JA, Newman JH. Hypoglycemia in hospitalized patients. Causes and outcomes. N Engl J Med 1986;315:1245-1250.
37. Seltzer HS. Drug-induced hypoglycemia. A review of 1418 cases. Endocrinol Metab Clin North Am 1989;18:163-183.
38. Kwong PY, Teale JD. Screening for sulphonylureas in the investigation of hypoglycaemia. J R Soc Med 2002;95:381-385.
39. van Staa T, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 1997;50:735-741.
40. Cryer PE. Symptoms of hypoglycemia, thresholds for their occurrence, and hypoglycemia unawareness. Endocrinol Metab Clin North Am 1999;28:495-500.
41. Service FJ. Recurrent hyperinsulinemic hypoglycemia caused by an insulin-secreting insulinoma. Nat Clin Pract Endocrinol Metab 2006;2:467-470.
42. Grant CS. Surgical aspects of hyperinsulinemic hypoglycemia. Endocrinol Metab Clin North Am 1999;28:533-554.
43. Galiber AK, Reading CC, Charboneau JW, Sheedy PF 2nd, James EM, Gorman B, et al. Localization of pancreatic insulinoma: comparison of pre- and intraoperative US with CT and angiography. Radiology 1988;166:405-408.
44. Zografos GN, Stathopoulou A, Mitropapas G, Karoubalis J, Kontogeorgos G, Kaltsas G, et al. Preoperative imaging and localization of small sized insulinoma with EUS-guided fine needle tattoing: a case report. Hormones (Athens) 2005;4: 111-116.
45. Fedorak IJ, Ko TC, Gordon D, Flisak M, Prinz RA. Localization of islet cell tumors of the pancreas: a review of current techniques. Surgery 1993;113:242-249.
46. Iwanaka T, Matsumoto M, Yoshikawa Y, Koda N, Mochizuki H, Aihara T, et al. Accurate localization of an insulinoma by preoperative selective intra-arterial calcium injection and intraoperative glucose monitoring. Pediatr Surg Int 2000;16: 118-120.
47. Thompson NW, Czako PF, Fritts LL, Bude R, Bansal R, Nostrant TT, et al. Role of endoscopic ultrasonography in the localization of insulinomas and gastrinomas. Surgery 1994;116:1131-1138.
48. Vinik AI, Delbridge L, Moattari R, Cho K, Thompson N. Transhepatic portal vein catheterization for localization of insulinomas: a ten-year experience. Surgery 1991;109:1-11.
49. Hiramoto JS, Feldstein VA, LaBerge JM, Norton JA. Intraoperative ultrasound and preoperative localization detects all occult insulinomas. Arch Surg 2001;136:1020-1025.
50. Kurosaki Y, Kuramoto K, Itai Y. Hyperattenuating insulinoma at unenhanced CT. Abdom Imaging 1996;21:334-336.
51. Doppman JL, Miller DL, Chang R, Shawker TH, Gorden P, Norton JA. Insulinomas: localization with selective intraarterial injection of calcium. Radiology 1991;178:237-241.
52. Norton JA, Shawker TH, Doppman JL, Miller DL, Fraker DL, Cromack DT, et al. Localization and surgical treatment of occult insulinomas. Ann Surg 1990;212:615-620.
53. Smith TR, Koenigsberg M. Low-density insulinoma on dynamic CT. AJR Am J Roentgenol 1990;155:995-996.
54. Ichikawa T, Peterson MS, Federle MP, Baron RL, Haradome H, Kawamori Y, et al. Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology 2000; 216:163-171.
55. Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 2000;214:483-490.
56. Matsuki M, Inada Y, Nakai G, Tatsugami F, Tanikake M, Narabayashi I, et al. Diffusion-weighed MR imaging of pancreatic carcinoma. Abdom Imaging 2007;32:481-483.
57. Lee SS, Byun JH, Park BJ, Park SH, Kim N, Park B, et al. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses. J Magn Reson Imaging 2008;28:928-936.
58. Jackson JE. Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2005;19: 229-239.
59. Tsagarakis S, Kaskarelis J, Malagari C, Platis O, Trivizas P, Vrachliotis G, et al. Regionalization of occult pancreatic insulinomas with the arterial stimulation venous sampling (ASVS) technique. Clin Endocrinol (Oxf) 1997;47:753-757.
60. Horino T, Takao T, Hashimoto K. A case with insulinoma diagnosed and localized preoperatively using contrastenhanced ultrasonography (CEUS) and arterial stimulation and venous sampling (ASVS). Endocr J 2006;53:141-146.
61. Lo CY, Chan FL, Tam SC, Cheng PW, Fan ST, Lam KS. Value of intra-arterial calcium stimulated venous sampling for regionalization of pancreatic insulinomas. Surgery 2000;128: 903-909.
62. Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 2004;25:458-511.
63. Shin LK, Brant-Zawadzki G, Kamaya A, Jeffrey RB. Intraoperative ultrasound of the pancreas. Ultrasound Q 2009;25:39-48.
64. Norton JA. Intraoperative methods to stage and localize pancreatic and duodenal tumors. Ann Oncol 1999;10:182-184.
65. Balon HR, Goldsmith SJ, Siegel BA, Silberstein EB, Krenning EP, Lang O, et al. Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide. J Nucl Med 2001;42:1134-1138.
66. de Herder WW, Niederle B, Scoazec JY, Pauwels S, Kloppel G, Falconi M, et al. Well-differentiated pancreatic tumor/ carcinoma: insulinoma. Neuroendocrinology 2006;84:183-188.
67. Cohen MS, Bower RH, Fidler SM, Johnsonbaugh RE, Sode J. Inhibition of insulin release by diphenylhydantoin and diazoxide in a patient with benign insulinoma. Lancet 1973; 1:40-41.
68. Brodows RG, Campbell RG. Control of refractory fasting hypoglycemia in a patient with suspected insulinoma with diphenylhydantoin. J Clin Endocrinol Metab 1974;38:159-162.
69. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996;334:246-254.
70. Stehouwer CD, Lems WF, Fischer HR, Hackeng WH, Naafs MA. Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide(Sandostatin). Acta Endocrinol (Copenh) 1989;121:34-40.
71. Lo CY, Lam KY, Fan ST. Surgical strategy for insulinomas in multiple endocrine neoplasia type I. Am J Surg 1998;175:305-307.
72. Hirshberg B, Libutti SK, Alexander HR, Bartlett DL, Cochran C, Livi A, et al. Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. J Am Coll Surg 2002;194:761-764.
73. Cuschieri A, Jakimowicz JJ, van Spreeuwel J. Laparoscopic distal 70% pancreatectomy and splenectomy for chronic pancreatitis. Ann Surg 1996;223:280-285.
74. Zografos GN, Vasiliadis G, Karoubalis J, Tsagarakis S. Laparoscopic resection of insulinoma after endoscopic ultrasonography tattooing. Am Surg 2010;76:446-448.
75. Gress FG, Barawi M, Kim D, Grendell JH. Preoperative localization of a neuroendocrine tumor of the pancreas with EUS-guided fine needle tattooing. Gastrointest Endosc 2002;55:594-597.
76. Karaliotas C, Sgourakis G. Laparoscopic versus open enucleation for solitary insulinoma in the body and tail of the pancreas. J Gastrointest Surg 2009;13:1869.
77. Lai EC, Lau SH, Lau WY. Measures to prevent pancreatic fistula after pancreatoduodenectomy: a comprehensive review. Arch Surg 2009;144:1074-1080.
78. Uemura K, Murakami Y, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, et al. Combination of polyglicolic acid felt and fibrin glue for prevention of pancreatic fistula following pancreaticoduodenectomy. Hepatogastroenterology 2009;56:1538-1541.
79. Stabile Ianora AA, Muscogiuri E, Scardapane A, Angelelli G. Multislice CT in the study of insulinomas: preliminary experience. Radiol Med 2004;107:325-331.
80. Galbut DL, Markowitz AM. Insulinoma: diagnosis, surgical management and long-term follow-up. Am J Surg 1980;139: 682-690.